BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HSK41959 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HSK41959\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07699757-2523@assetmemo.bio
DTSTAMP:20261121T005724Z
DTSTART;VALUE=DATE:20290430
DTEND;VALUE=DATE:20290501
SUMMARY:HSK41959: Phase 1 readout est. (NCT07699757)
DESCRIPTION:HSK41959\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: HSK419
 59 With Standard Therapy in Solid Tumors With MTAP Deletion\nEstimated pri
 mary completion: April 2029. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/hsk41959#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07699757
URL:https://assetmemo.bio/drug/hsk41959#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
